The **TPMT & NUDT15 Genotyping by RT-PCR** test is a genetic analysis used to detect variations in the *TPMT* (Thiopurine S-methyltransferase) and *NUDT15* (Nudix Hydrolase 15) genes. These genes influence how the body metabolizes thiopurine drugs, which are commonly prescribed for conditions like leukemia, inflammatory bowel disease, and autoimmune disorders. Doctors order this test to identify patients at risk of severe drug toxicity, allowing them to tailor medication doses safely and prevent harmful side effects during treatment.
Yes, it identifies genetic variations that increase risk of severe side effects from thiopurine drugs, allowing safer treatment planning.
Certainly, counseling helps patients understand results, inheritance patterns, and implications for family members.
Yes, it predicts susceptibility to severe bone marrow toxicity from thiopurine drugs.
No, genetic variations remain constant throughout life, so repeat testing is not needed.
Yes, it helps predict risk of adverse drug reactions and guides safe therapy.
No, it predicts risk before therapy but does not monitor ongoing treatment.
Yes, it helps optimize thiopurine therapy in leukemia treatment.
No, this is a genetic test, so medications do not alter results.
...
Didn't recieved OTP Yet? Resend OTP